UCSF
UC San Francisco Previously Published Works
Title
SUBOPTIMAL INTERPREGNANCY INTERVALS AND TIMING OF CONTRACEPTIVE PROVISION
AMONG ADOLESCENTS
Permalink
https://escholarship.org/uc/item/3ph8z6p6
Journal
CONTRACEPTION, 86(3)
ISSN
0010-7824
Authors
Isquick, S
Chang, R
De Bocanegra, H Thiel
et al.
Publication Date
2012-09-01
DOI
10.1016/j.contraception.2012.05.098
Peer reviewed
eScholarship.org
Powered by the California Digital Library
University of California
ABSTRACTS / Contraception 86 (2012) 290–325
Objectives: To understand how young black women conceptualize
contraception and interactions with their clinicians regarding pregnancy
prevention.
Methods: We conducted semi-structured qualitative interviews with
fifteen young black women, aged 18–23. Qualitative data were analyzed
using techniques informed by grounded theory. Initial codes were then
grouped thematically into subthemes. We analyzed the relationships
among the themes and the ways in which women portrayed themselves
and their interactions with clinicians, and grouped the subthemes into
larger concepts.
Results: Participants discussed two salient concepts in the context of
pregnancy prevention: (1) sexual responsibility and self-efficacy in
pregnancy prevention and (2) the perceived role of health care clinicians.
Throughout their narratives, women portrayed themselves as responsible
actors in control of their contraceptive decision making and practices.
Many viewed their life plan, to finish school and gain financial stability,
as crucial to their resolve to use contraceptives. Some noted that friends
had intended pregnancies, as a result of being lonely, not having other
opportunities, or following a social trend. The majority maintained a
sense of pride in not being pregnant, and believed others who did get
pregnant were lazy and irresponsible for not using contraceptives. Most
had limited expectations of clinicians and considered in-depth conversations about sexual behavior or details of contraceptive use to be
irrelevant and unnecessary.
Conclusions: These findings may prompt clinicians to better understand
how young black women view themselves as actors in the prevention of
pregnancy and highlight what this population seeks from caregivers.
P53
CONTRACEPTIVE ADHERENCE IN THE VA
HEALTHCARE SYSTEM
Borrero S
University of Pittsburgh, Pittsburgh, USA
Schwarz E, Zhao X, Mor M, Gellad W
Objectives: To evaluate contraceptive adherence among women veterans
who receive care in the Veterans Affairs (VA) Healthcare System.
Methods: We examined national VA databases for women aged 18–45 who
had made ≥1 visit to a VA primary care clinic and received ≥1 VA
prescription for contraception (pills, ring, patch or injectable) during 2008.
Women who had also used a long-acting or permanent method in 2008 were
excluded. Adherence was assessed using several indicators: filling ≥10
months of contraceptive supplies, obtaining refills ≥7 days late and
discontinuation (N90 days without contraception). Key independent
variables included race/ethnicity and months of supply dispensed.
Multivariable logistic regression models were used to examine associations
between independent variables and adherence.
Results: Of the 14,853 women in our sample, 7% were Hispanic, 44% white
and 24% were black (21% had missing information on race), and 81%
received a 3-month supply of contraceptives. Only 30% of women had ≥10
months of contraceptive coverage, 56% obtained refills ≥7 days late and
29% discontinued their method during the year. In multivariable analyses,
Hispanics and blacks were less likely than whites to have ≥10 months of
contraceptive supplies (OR 0.60, 95% CI 0.51–0.71 and OR 0.73, 95% CI
0.66–0.81) and more likely to discontinue their method (OR 1.28, 95% CI
1.11–1.48 and OR 1.23, 95% CI 1.12–1.39). Hispanics were more likely
than whites to obtain refills late (OR 1.19, 95% CI 1.01–1.40). Compared
with receiving a b3-month supply, receiving a 3-month supply was
associated with ≥ 10 months of contraception coverage (OR 1.15, 95% CI
1.04–1.27), lower odds of a gap (OR 0.80, 95% CI 0.73–0.88) and less
discontinuation (OR 0.84, 95% CI 0.77–0.92).
Conclusions: Interventions to enhance contraceptive adherence among
women veterans are needed.
311
P54
INCREASING CONTRACEPTION COUNSELING IN
SUBSPECIALTY MEDICINE CLINICS WITH A
CHART-BASED PROMPT
Benfield N
Albert Einstein College of Medicine, Bronx, NY, USA
Berrios S, Harleman E, Jackson R
Objectives: To measure the impact of a chart-based provider prompts on
contraception counseling and provision for women with chronic medical
conditions seeing their subspecialty provider at an urban county hospital.
Methods: This is a cross-sectional study at three time-points in neurology,
rheumatology and diabetes clinics at San Francisco General Hospital.
Reproductive age women who attended the clinics prior to prompt use,
immediately after prompt roll-out, and 6 months into prompt use were eligible
and completed questionnaires after their provider visits. The prompt was a onepage form listing available contraceptives, with a checklist to assist counseling,
provision, and referral for women with medical conditions.
Results: The study included a total of 189 total participants: 77 pre-prompt, 72
post-prompt, 40 6-month; 60.8% from neurology, 24.9% from rheumatology
and 14.3% from diabetes. Average age was 32.6 years (18–45), with an
ethnically and socioeconomically diverse sample. Contraceptive discussions
increased from 9.2% to 36.8% (pb.0005), with an adjusted OR of 5.9 (95% CI
2.4–14.4). This increase was sustained at 6 months with a contraception
discussion rate of 40%, and was seen in each clinic. A contraceptive plan,
which included birth control prescriptions and referrals, increased from 3.6%
to 7.9%, but this was not significant (p=.24). Amongst those in whom the
prompt was located (N=95), use of the prompt was associated with increased
contraceptive discussions at an adjusted OR of 7.1 (95% CI 2.3–21.1).
Conclusions: This simple chart prompt was able to significantly increase
patient-provider contraceptive discussions across a variety of subspecialty
clinics for medically high-risk women. This concept has expansion potential
and could be easily integrated into an electronic medical record. Future efforts
must focus on facilitating contraceptive prescriptions and referrals.
P55
SUBOPTIMAL INTERPREGNANCY INTERVALS AND TIMING
OF CONTRACEPTIVE PROVISION AMONG ADOLESCENTS
Isquick S
Bixby Center for Global Reproductive Health, University of California, San
Francisco, San Francisco, California, USA
Chang R, de Bocanegra H Thiel, Chabot M, Brindis CD
Objectives: The study examined the timing and type of contraceptive uptake
among adolescents with suboptimal interpregnancy intervals (IPIs).
Methods: We identified second- or higher order births from California's
2008 Birth Statistical Master File of women aged nineteen and younger at
last live birth and calculated the birth-to-conception interval between the
date of the previous live birth and the conception date of the birth in 2008.
We conducted a probabilistic linking methodology to identify teens
receiving contraceptive services from Family PACT (California's Medicaid
family planning expansion). Suboptimal IPIs were defined as b18 months.
Results: Among the 32,257 adolescents with second- or higher order births
receiving Family PACT services, 37% had suboptimal IPIs. Among this
subgroup, 22% received a contraceptive method at first visit, compared to
34% of adolescents with optimal IPIs. Among adolescents who first received
a contraceptive method at any visit, the highest percentage of suboptimal
IPIs occurred among those making 6–10 and 10–15 visits before receiving a
method (30% each), while the lowest percentage of suboptimal IPIs (24%)
occurred among clients receiving a method at first visit.
312
ABSTRACTS / Contraception 86 (2012) 290–325
Adolescents with the least contraceptive coverage (0–2 months) had the
highest percentage of suboptimal IPIs (30%), while adolescents with the
most coverage (13–18 months) had the lowest percentage of suboptimal
IPIs (13%).
Conclusions: Contraceptive provision at first visit and contraceptive
coverage optimization help reduce suboptimal IPIs among adolescents.
Further research is needed to understand the personal and systemic factors
influencing delays in contraceptive uptake and suboptimal IPIs among
adolescents receiving contraception.
P56
HIGH-RISK SEXUAL PRACTICES AND CONTRACEPTION IN
COLLEGE FRESHMEN
Zapata M
University of Michigan, Ann Arbor, MI, USA
Jibril F, Zochowski M, Harris L, Dalton V, Parvataneni R
Objectives: It is thought the freshman year of college is associated with
onset or increase in sexual activity and high-risk behaviors. We aim to
describe initial sexual behavior, contraceptive choices and high-risk sexual
practices in freshman females at a large state university.
Methods: A total of 700 females randomly selected from the University of
California–Los Angeles 2011 incoming freshman class received an e-mail
invitation for study participation. Respondents were screened online for
eligibility criteria. For those who were eligible, Web-based consent was
obtained and subjects completed an anonymous, self-administered electronic
questionnaire during the beginning of the academic year. Subjects
completing the first survey will be asked to complete a second questionnaire
at the end of the academic year (June 2012).
Results: Of the 700 students invited to participate, 230 responded
(32.9% response rate); 208 met eligibility criteria and completed the
survey. Upon entering freshman year, 39.3% (n=80) were sexually
active. Among sexually active respondents at last intercourse, 6.2%
(n=5) reported using no form of contraception; 60% (n=48) reported
condom use; 66.3% (n=53) reported using oral contraceptive pills; 7.6%
(n=8) reported using LARC (long-acting reversible contraception). Fifty
percent (n=104) reported alcohol use and 18% (n=38) tobacco use
before college. When choosing contraception, 76% (n=155) trust their
clinician most for information; 56.2% (n=114) would use a method if
their clinician were using.
Conclusions: Rates of unprotected vaginal intercourse were lower than
in other published reports on this age-group. Trust in clinicians for
contraceptive information is high, and sharing of personal use may
influence this population. Prospective follow-up data will be completed
in June 2012.
P57
USING CHANGES IN BINDING GLOBULINS TO ASSESS ORAL
CONTRACEPTIVE PILL COMPLIANCE
Petrie K
Department of Obstetrics and Gynecology, Columbia University Medical
Center, New York, NY, USA
Westhoff C, Cremers S
Objectives: Measuring ethinyl estradiol (EE2) induced changes in binding
globulin (BG) levels may provide an effective and convenient approach to
distinguishing noncompliant from compliant oral contraceptive pill (OCP)
users in research settings. This analysis evaluated the validity of using
changes in corticosteroid-binding globulin (CBG), sex-hormone-binding
globulin (SHBG), thyroxine-binding globulin (TBG), as measures of OCP
compliance.
Methods: We used frozen serum from a 3-month study that compared
ovarian suppression between normal weight and obese women
randomized to one of two OCP formulations — either 30 mcg EE2
and 150 mcg levonorgestrel (LNG) or 20 mcg EE2 and 100 mcg LNG.
Based on serial LNG measurements, 17% of participants were
noncompliant. With only OCP starters included, each noncompliant
participant was matched with compliant participants by age, body mass
index, OCP formulation, and ethnicity. We measured CBG, SHBG and
TBG levels, and compared the changes from baseline to 3-month
follow-up between the noncompliant and compliant study participants.
We then constructed receiver operator characteristic curves to assess the
sensitivity and specificity of using change in BGs to measure OCP
compliance.
Results: Change in CBG and TBG had excellent sensitivity and specificity
to distinguish OCP noncompliant users from compliant users. SHBG was
less useful.
Conclusions: EE2 induced changes in CBG and TBG provide a sensitive
integrated marker of compliance with an LNG containing OCP. Measuring
BG changes to evaluate OCP compliance can be done with a standardized,
readily available kit. This requires drawing only 2 blood samples: at baseline
and at a single follow-up. In OCPs containing EE2 and progestin
components, SHBG might be useful.
P58
THE EFFECT OF PROGESTIN-ONLY CONTRACEPTION ON
POSTPARTUM WEIGHT LOSS (POPP)
Pentlicky S
University of Pennsylvania, Philadelphia, PA, USA
Ratcliffe S, Schreiber C
Objectives: Obesity and unplanned pregnancies are leading public health
problems. The postpartum period is a unique time when these two
conditions overlap. We aim to understand how progestin-only
contraceptives affect postpartum weight. We hypothesize that by 6
months after delivery, etonogestrel implant users will lose an amount of
weight similar to that lost by women in a control group, while depot
medroxyprogesterone acetate (DMPA) users will retain more pregnancy
weight.
Methods: A total of 100 women were enrolled immediately postpartum; 34
of these self-selected to leave the hospital without initiating contraception.
Sixty-six women randomly received either the etonogestrel implant or
DMPA prior to discharge. Descriptive statistics were used to assess
differences among the groups. Generalized estimating equations were used
to analyze intrapersonal weight changes, which were then adjusted for age,
race/ethnicity, parity, income and education.
Results: Compared with controls, randomized women were 5 years
younger (pb.0001) and more often black (p=.002). At 3 months, DMPA
users had lost 5.8 lb (2.9%), etonogestrel implant users had lost 12.5 lb
(7.1%) and the controls had lost 14.9 lb (8.5%). The difference in
percentage weight change at 3 months between the DMPA users and the
controls was significant (p=.012); however, the change between the
etonogestrel implant users and the controls was not (p=.073). At 6
months, DMPA users had a significantly different weight-loss trajectory
than the control group (p=.0497).
Conclusions: Our data demonstrate weight-loss differences between
postpartum women using DMPA and those using the etonogestrel
implant or non-hormonal contraceptives. Our findings emphasize the
importance of understanding the intersection of contraception and
obesity, which will aid in the amelioration of these public health
epidemics.